已收盘 01-30 16:00:00 美东时间
-0.057
-0.22%
BRIEF-Usa Rare Earth Announces Closing Of $1.5 Billion Pipe Financing Jan 29 (Reuters) - USA Rare Earth Inc USAR.O : USA RARE EARTH ANNOUNCES CLOSING OF $1.5 BILLION PIPE FINANCING Source text: ID:nGNX52Fp1q Further company coverage: USAR.O (( Reuters.Briefs@thomsonreuters.com ;))
01-29 20:29
BRIEF-Vallourec Announce Strategic Partnership With XGS Energy Jan 28 (Reuters) - Vallourec SA VLLP.PA : ANNOUNCE STRATEGIC PARTNERSHIP WITH XGS ENERGY PARTNERSHIP ON THREE-GIGAWATT PIPELINE OF COMMERCIAL GEOTHERMAL PROJECTS ACROSS WESTERN UNITED STATES Source text: ID:nGNX6XDLpk Further company cov
01-29 01:02
FOCUS-Kuwait readies $7 billion pipeline deal as Gulf turns to foreign capital Kuwait planning $7 billion pipeline stake sale in Feb -sources KPC has added HSBC to list of advisers on deal -sources Saudi Aramco plans $4 bln power plant sale within weeks -sources Up to $15 bln in infrastructure deals
01-28 23:32
Mawson Infrastructure Sues Endeavor Blockchain Over Alleged Securities Law Violations Mawson Infrastructure Group Inc. has filed a lawsuit in the United States District Court for the District of Delaware against Endeavor Blockchain, LLC, Joshua Kilgore, PM Squared, LLC, Cody Smith, and Phil Stanley.
01-22 19:04
Kinder Morgan beats Q4 revenue and profit estimates Overview Energy infrastructure firm's Q4 revenue beat analysts' expectations Adjusted EPS also beat analysts' estimates Company highlighted role in U.S. LNG exports and natural gas infrastructure Outlook Kinder Morgan expects 2026 adjusted net inco
01-22 05:13
AEON Biopharma Secures Shareholder Approval for PIPE Financing AEON Biopharma Inc. announced that its shareholders have approved the completion of transactions announced in November, which include the remaining issuances related to the company's private investment in public equity (PIPE) financing a
01-22 05:06
AEON Biopharma Inc. Held Shareholder Meeting AEON Biopharma Inc. held a special meeting on January 21, 2026. Shareholders approved the proposals required to complete the transactions announced in November, including the remaining issuances related to the company's private investment in public equity
01-22 05:05
BRIEF-Actuate Therapeutics Announces Plans To Expand Clinical Pipeline, Advancing Elraglusib Tablet Into A Phase 1/2 Clinical Program In Refractory Cancers Jan 21 (Reuters) - Actuate Therapeutics Inc ACTU.O : ACTUATE THERAPEUTICS ANNOUNCES PLANS TO EXPAND CLINICAL PIPELINE, ADVANCING ELRAGLUSIB TABL
01-21 21:46